Background: Gestational diabetes mellitus can be defined as 'glucose intolerance or hyperglycaemia with onset or first recognition during pregnancy.' Objective: The objective of our systematic review was to see if there was any intervention that could be used for primary prevention of gestational diabetes mellitus in women with risk factors for gestational diabetes mellitus.
Introduction
Gestational diabetes mellitus (GDM) can be defined as 'glucose intolerance or hyperglycaemia with onset or first recognition during pregnancy.' [1] [2] [3] [4] Worldwide GDM incidence varies depending on risk factors within communities but its estimated incidence is between 2 and 8% of all pregnancies. [4] [5] [6] [7] [8] Maternal hyperglycaemia results in fetal hyperglycaemia and macrosomia leading to shoulder dystocia, birth trauma, perinatal death, neonatal hypoglycaemia and long-term risk of obesity and diabetes in the child. The maternal risks include increased incidence of caesarean section, increased rates of induction of labour and its associated sequelae and subsequent development of type 2 diabetes mellitus.
The NICE guideline detailed a screening programme targeting biochemical screening to women with the following risk factors 4 BMI 30 kg/m 2 ; previous macrosomia 4500 g; previous GDM, first-degree relative with diabetes; family origin group with high risk of diabetes. 4 Data on recent trends in maternal age at birth and on the prevalence of overweight and obesity indicate that women are older and heavier when having children, which will increase the prevalence of GDM. [6] [7] [8] [9] [10] [11] [12] [13] The IADPSG consensus 14 recommends a one-step 75 g OGTT for all women not already known to be diabetic at 24 to 28 weeks of gestation and diabetes is diagnosed where one or more threshold values is exceeded (fasting 5.1 mmol/ L, 1 h 10.0 mmol/L, 2 h 8.5 mmol/L). Application of these criteria is predicted to result in per pregnancy incidence of GDM of over 16% from the current level of 3.5%. 14 The potential benefits of recognising and treating GDM include reductions in ill health in the woman and/or the baby during or immediately after pregnancy, as well as the benefits of reducing the risk of progression to type 2 diabetes in the longer term. 4, 5, [15] [16] [17] Treatment of GDM is within a multidisciplinary environment which includes lifestyle interventions, such as diet, exercise, self-monitoring of blood glucose and hypoglycaemic therapy. 16, 17 It has been estimated that an average additional cost per mother with GDM is 1733 and cost per newborn to mother with GDM is 110. 18 When taking into account the short-and long-term risks, for both mother and neonate, and the interventions required for women diagnosed with GDM, primary prevention would be beneficial to both the individual and would reduce the health cost burden of diagnosis.
The objective of our systematic review was to see if there was any intervention which could be used for primary prevention of GDM in women with risk factors for GDM.
Methods
A prospective peer-reviewed protocol was prepared a priori. Metaanalysis was performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) statement. 19 All published randomised or quasi-randomised controlled trials comparing intervention with standard care in women with risk factors for GDM were included. Risk factors included raised BMI, previous GDM, previous infant with birth weight greater than 4500 g, family history of diabetes, high-risk ethnic groups and polycystic ovarian syndrome (PCOS). The interventions were sub-grouped into diet versus standard management; exercise versus standard management; lifestyle (diet, exercise, weight check at each visit) intervention versus standard management and pharmacological intervention versus standard management.
Trials comparing interventions in pregnant women with no risk factors for GDM and one intervention versus another were excluded. There were no exclusion criteria based on language or publication status. Studies were identified through Medline, Embase, Cochrane specialised trials register, ClinicalTrials.gov, conference abstract databases from 1966 to August 2012. A literature search was performed independently in August 2012 by two authors (PM and GG) using search terms Pregnancy/Gestational Diabetes/Prevention/Obesity/ Previous gestational diabetes/Dietary intervention/Lifestyle intervention/Exercise/Pharmacological intervention/Metformin. All titles were screened and studies excluded if obviously irrelevant. If there was any doubt concerning the eligibility of the study, abstracts were examined and if necessary, the full text. Data were extracted independently by two authors (PM and GG). If any disagreements arose the complete paper was reviewed and disagreements resolved by discussion between the two authors (GG and PM). If we had not been able to agree we would have contacted a third author. Extracted data were put into a spreadsheet that had been developed prior to conducting the study. Authors were contacted if supplementary information was required.
The primary outcome assessed was the incidence of GDM. The secondary outcomes were caesarean section rate, fetal macrosomia (44000 g), large for gestational age (LGA) (90th percentile for gestational age), small for gestational age (SGA) (10th percentile for gestational age), mean birth weight, pre-eclampsia (blood pressure 140/90 on two separate occasions with 1þ proteinuria arising after 20 weeks of gestation), gestational hypertension (blood pressure 140/90 on two separate occasions arising after 20 weeks of gestation), induction of labour, preterm birth (Birth before 37 weeks), shoulder dystocia, neonatal hypoglycaemia (52.0 mmol/L), perinatal mortality and health cost analysis.
Data analysis
Data were analysed using Review Manager 5 (Cochrane Collaboration, Oxford, UK); Odds ratios (ORs) and weighted mean difference (WMD) were used as summary measures. Methodological heterogeneity was assessed during the selection, and statistical heterogeneity was measured using the chi-square test and I 2 scores. A random effect model 20 was used throughout to reduce the effect of statistical heterogeneity. Risk of bias across studies was assessed using risk of bias tables generated through Review Manager. Sensitivity analysis was performed by excluding studies with unclear quality. Funnel plots were not used to measure publication bias because of the small number of studies and their similar sizes. Outcomes for obese women reported separately which was utilised for the analysis.
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Test for overall effect: Z = 1.78 (P = 0.07) Figure 1 describes the literature search outcome. In all, 14 randomised controlled trials (RCTs) were included with a total of 2422 women (Table 1) comparing: diet (three RCTs; n ¼ 455), exercise (three RCTs; n ¼ 183), lifestyle changes (six RCTs; n ¼ 1470) and drugs (two RCTs; n ¼ 314) with standard care in women with risk factors for GDM. Twelve studies were excluded; reasons for exclusion are listed in Table 2 . A total of 302 (12.5%) women were lost to follow-up. The mean age was 28.8 years and mean BMI was 31.6 kg/m 2 .
Metformin versus standard care

Results
Comparison of diet versus standard care
Three studies compared diet with standard antenatal care. 21 Primary outcome. All three studies reported the incidence of GDM;
there was a statistically significantly lower incidence of GDM (OR 0.33, 95% CI 0.14 to 0.76) with dietary intervention compared to standard care (diet 7% vs standard care 18%) ( Figure 2 ). Secondary outcomes. Meta-analysis of two studies 22,23 showed a statistically significant lower incidence of gestational hypertension with dietary intervention compared to standard care (OR 0.28, 95% CI 0.09 to 0.86) (Figure 8 ). There was no statistically significant difference in the rates of macrosomia, caesarean section, pre-eclampsia, induction of labour, preterm birth and mean birth weight ( Figures 5, 6 
Exercise versus standard care
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Comparison of exercise versus standard care
Three studies compared exercise with standard antenatal care. 15, 24, 25 A total of 183 women were included; 50 were lost to follow-up. Mean age (Exercise group 30.4 years vs standard care group 30.5 years) and BMI (Exercise group 34.05 kg/m 2 vs standard care group 34.5 kg/m 2 ) were comparable between the groups. Primary outcome. All three studies reported the incidence of GDM; there was no statistically significant difference in the incidence of GDM (OR 0.77, 95% CI 0.33 to 01.79) between the groups (Figure 2 ).
Secondary outcomes.
There was no statistically significant difference in the rates of LGA and caesarean section between the groups (Figures 3 and 6) . Fasting blood glucose and mean birth weight of both the groups were similar (Figures 3 and 12 ).
Comparison of lifestyle changes versus standard care
Six studies compared lifestyle changes with standard antenatal care. 26 Primary outcome. All six studies reported the incidence of GDM; there was no statistically significant difference in the incidence of GDM (OR 1.44, 95% CI 0.96 to 2.14) between the groups (Figure 2 ). Secondary outcomes. There was no statistically significant difference in the rates of LGA, macrosomia, caesarean section, SGA, pre-eclampsia, gestational hypertension, induction of labour, preterm birth and mean birth weight (Figures 4-12 ).
Comparison of metformin versus standard care
Two studies compared metformin with standard antenatal care. 32 Primary outcome. Both studies reported the incidence of GDM; there was no statistically significant difference in the incidence of GDM (OR 1.04, 95% CI 0.60 to 1.92) between the groups (Figure 2 ).
Secondary outcomes.
There was no statistically significant difference in the rates of macrosomia, caesarean section, SGA, pre-eclampsia, Study or Subgroup Thornton 2009 Subtotal (95% CI)
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Health economic evaluation
None of the studies assessed the cost to health services.
Heterogeneity
Methodological heterogeneity was assessed before analysis. No studies were excluded on the basis of methodological heterogeneity. There was a low estimate of statistical heterogeneity (I 2 25%) in GDM (comparison Diet vs Standard care). There was moderate heterogeneity (I 2 between 25% and 75%) in Fasting blood glucose (comparison exercise vs standard care), LGA (Comparison diet and exercise vs standard care), caesarean section (comparison Diet and exercise vs standard care) and Mean Birth Weight (Comparison Diet and exercise vs standard care and metformin vs standard care).
Risk of bias
The risk of bias was assessed using a risk-of-bias graph (Figure 13 ). Allocation concealment and blinding were poorly reported.
Discussion
Main findings
GDM continues to be a challenging obstetric condition and the incidence is increasing. This review has evaluated primary prevention of GDM in women who have risk factors for developing GDM during pregnancy. We have found that dietary interventions have demonstrated a significantly reduced rate of GDM and gestational hypertension in pregnant women with risk factors for GDM but lifestyle, exercise or drug interventions have not. Healthy eating advice by a trained dietician, weighing at each antenatal visit and review of food records were utilised by all three included dietary intervention trials, however the number of follow-up visits and duration of each consultation were variable. Thornton 2009 Wolffs 2008 Subtotal (95% CI)
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Strengths and limitations
This review has several strengths. The search was thorough and systematic without language restrictions. Two reviewers independently performed the study selection and data extraction to minimise errors. We contacted the authors for unpublished information. We adhered to PRISMA 19 statement in reporting our review. We used the random effect model 20 throughout the meta-analysis and therefore reduced the impact of statistical heterogeneity. Our inclusion criteria were well defined with only high-risk women, thus targeting a specific cohort of women to whom the interventions could be applied. Obviously, with all interventions there are cost implications and by limiting interventions to a high-risk group, rather than the entire pregnant population, it is more likely that the intervention will be cost-effective to run as the risk/benefit ratio will be greater.
Our review has a number of limitations: methodological heterogeneity, whilst only high-risk women were included, this is still a heterogeneous group with all risk factors (modifiable and non-modifiable) for GDM, different dietary and exercise interventions used by the trialist and also different diagnostic criteria used to diagnose GDM by different trialist. Small numbers of studies were included in the meta-analysis and not all outcomes were reported by the trials included in the review. The allocation concealment and blinding of outcome assessor were not reported in most studies.
Interpretation
Oostdam et al. 47 conducted a similar systematic review which included all pregnant women not just high-risk women, therefore a heterogeneous group. They also found dietary intervention significantly reduced the incidence of GDM in pregnant women. The results of Oostdam et al.'s systematic review also suggest that a low glycaemic diet reduced the risk of LGA and exercise programme significantly reduced macrosomia. Our review did not show a significant difference in LGA or macrosomia rates with any of the interventions.
Thangaratinam et al. 48 conducted a systematic review to evaluate the effect of dietary and lifestyle interventions in pregnancy on maternal and fetal weight. They concluded that among the interventions, those based on diet are the most effective and are associated with significant reductions in maternal weight gain, pre-eclampsia, GDM, gestational hypertension and preterm labour. However their review included trials on women with any BMI, obese and overweight or only obese women, women with diagnosis of GDM and with pre-existing diabetes, therefore a heterogeneous group unlike our review which included only trials with pregnant women with risk factors for GDM. Hence the application of the results of Thangaratinams et al.'s review to groups of women with risk factors cannot be justified.
A systematic review 49 to assess the benefits and harm of antenatal dietary or lifestyle interventions for pregnant women who are overweight or obese did not show any statistically significant difference for LGA infant, mean gestational weight gain, GDM, pre-eclampsia, preterm labour or caesarean section. However this review was published in 2010, since then several trials have been published, hence the difference in the results between this review and ours.
There are two Cochrane reviews 5,50 looking at primary prevention of GDM. Tieu et al. 50 looked at dietary advice in pregnancy for preventing GDM. Three trials were included in the review. One trial analysed high-fibre diets and two trials assessed low glycaemic index (LGI) versus high glycaemic index diets for pregnant women. Again all three trials included healthy pregnant women without any risk factors for GDM. Whilst they did not find a statistically significant difference in the incidence of GDM, they did find that there was a reduction in fasting blood sugars, LGA incidence, a reduction in Ponderal index and birth centiles with an LGI diet. These trials were excluded from our review as we included only trials performed on women with risk factors.
Han et al. 5 also published a Cochrane review looking at exercise and the incidence of GDM. Like our review they found no significant difference in the incidence of GDM and other outcomes. Again, they included all pregnant women not just highrisk women.
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Phelan 2011 Subtotal (95% CI)
Heterogeneity: Tau² = 0.02; Chi² = 10.56, df = 3 (P = 0.01); I² = 72%
Test for overall effect: Z = 0.23 (P = 0.82) Although dietary intervention significantly reduced the incidence of GDM and gestational hypertension, exercise and lifestyle intervention (which included diet, exercise) were not associated with statistically significant differences in any of the outcomes. Compliance with exercise was reported to be poor from second trimester in most of the trials which could be a reason for not finding a statistically significant difference with exercise. This situation mimics real life, thereby making the value of exercise in preventing GDM in pregnancy questionable. Moreover, dietary advice was provided by a qualified dietician, which included healthy eating, energy intake based on energy requirement, prescribed balanced regime (carbohydrate 40%, fat 30% and protein 30%) and review of food diary in all the diet-only trials. Whereas lifestyle intervention trials provided dietary intervention by a trained dietician, which included dietary advice in a group sessions, written information about healthy eating did not include a prescribed regime, intake based on energy requirement or food diary. This difference in the dietary intervention could explain the lower incidence of GDM with diet-only trials whereas there was no difference with the lifestyle intervention trials. Moreover, none of the trials reported per protocol analysis due to small numbers; therefore, the true effect of exercise and lifestyle intervention could not be assessed.
Metformin versus standard care
Conclusion
This review has demonstrated that dietary interventions have a statistically significant effect on the primary prevention of GDM and gestational hypertension in women who are at risk of developing GDM. No statistically significant difference was found for interventions involving exercise, lifestyle (dietary and exercise) or drug interventions. This evidence should be interpreted with caution as only a small number of trials were included. Whilst the results for dietary intervention and its role in primary prevention is encouraging, adequately powered larger multicentre RCTs using standardised dietary intervention and standardised outcome measures need to be performed to determine whether these interventions can be applied to women at risk of GDM. The cost of the interventions also needs to be calculated to identify if the interventions used are cost effective.
